Tanishka Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.42 Cr
- Company Age 19 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.92 Cr
- Satisfied Charges ₹ 2.54 Cr
- Revenue Growth -48.48%
- Profit Growth -48.42%
- Ebitda -18.52%
- Net Worth 4.00%
- Total Assets -21.90%
About Tanishka Pharmaceuticals
Tanishka Pharmaceuticals Private Limited (TPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 11 February 2005 and has a history of 19 years and 11 months. Its registered office is in Solan, Himachal Pradesh, India.
The Corporate was formerly known as Briskon Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.42 Cr.
The company currently has active open charges totaling ₹3.92 Cr. The company has closed loans amounting to ₹2.54 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jaswinder Singh, Davinder Singh, Rohtas Sharma, and One other member serve as directors at the Company.
Company Details
-
Location
Solan, Himachal Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U02423HP2005PTC000895
-
Company No.
000895
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Feb 2005
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Himachal Pradesh
Industry
Who are the key members and board of directors at Tanishka Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohtas Sharma
|
Additional Director | 12-Dec-2017 | Current |
|
Jaswinder Singh
|
Additional Director | 17-Apr-2023 | Current |
|
Davinder Singh
|
Additional Director | 12-Dec-2017 | Current |
|
Pankaj Kumar
|
Additional Director | 12-Dec-2017 | Current |
Financial Performance of Tanishka Pharmaceuticals.
Tanishka Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 48.48% decrease. The company also saw a substantial fall in profitability, with a 48.42% decrease in profit. The company's net worth moved up by a moderate rise of 4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tanishka Pharmaceuticals?
In 2023, Tanishka Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Medilente Pharma Private LimitedRohtas Sharma is a mutual person
-
Healthkind Labs Private LimitedRohtas Sharma is a mutual person
-
Zenacts Pharma Private LimitedPankaj Kumar is a mutual person
-
Angiolife Healthcare Private LimitedDavinder Singh is a mutual person
-
Zeylanica Pharmaceuticals Private LimitedJaswinder Singh is a mutual person
-
Healthserch Pharma LlpRohtas Sharma is a mutual person
Charges (Loans)
₹3.92 Cr
₹2.54 Cr
Charges Breakdown by Lending Institutions
- Others : 3.74 Cr
- Hdfc Bank Limited : 0.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2024 | Hdfc Bank Limited | ₹1.81 M | Open |
| 25 Mar 2021 | Others | ₹3.50 Cr | Open |
| 25 Mar 2021 | Others | ₹2.38 M | Open |
| 30 Oct 2018 | Others | ₹1.69 Cr | Satisfied |
| 27 Nov 2007 | Allahabad Bank | ₹8.50 M | Satisfied |
How Many Employees Work at Tanishka Pharmaceuticals?
Tanishka Pharmaceuticals has a workforce of 27 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tanishka Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tanishka Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
